Skip to main content
Clinical Trials/JPRN-UMIN000022726
JPRN-UMIN000022726
Completed
未知

Investigation of method for prediction of therapeutic effect of infliximab initial therapy for inflammatory bowel disease - IPININ study

Ofuna Chuo Hospital0 sites20 target enrollmentJune 14, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
lcerative colitis, Crohn&#39
Sponsor
Ofuna Chuo Hospital
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2016
End Date
December 31, 2017
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who are considered not suitable for Infliximab use due to contraindication or considerable risks such as hypersensitivity to Infliximab. Other than above mentioned criteria, patients who are judged inappropriate by the doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials